{
  "cik": 1861107,
  "cik_padded": "0001861107",
  "entityName": "Ceribell, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-067238",
      "filed": "2026-02-24",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 767000.0,
        "cash": 40476000.0,
        "cost_of_revenue": 10789000.0,
        "eps_diluted": -1.46,
        "free_cash_flow": -41575000.0,
        "gross_profit": 78274000.0,
        "net_income": -53412000.0,
        "operating_cash_flow": -40808000.0,
        "operating_income": -58402000.0,
        "revenue": 89063000.0,
        "stockholders_equity": 155336000.0,
        "total_assets": 195803000.0,
        "total_liabilities": 40467000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.8788610309556157,
        "leverage": 0.260512695061029,
        "net_margin": -0.5997103174157619,
        "operating_margin": -0.6557380730494144,
        "revenue_growth_yoy": 0.3609039789743903,
        "roa_avg2y": -0.25360920195149744,
        "roa_period_end": -0.2727843802188935,
        "roe_avg2y": -0.30829348255849187,
        "roe_period_end": -0.34384817428026987
      }
    },
    {
      "accn": "0001193125-26-067238",
      "filed": "2026-02-24",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1340000.0,
        "cash": 194370000.0,
        "cost_of_revenue": 8694000.0,
        "eps_diluted": -3.39,
        "free_cash_flow": -36383000.0,
        "gross_profit": 56750000.0,
        "net_income": -40455000.0,
        "operating_cash_flow": -35043000.0,
        "operating_income": -39709000.0,
        "revenue": 65444000.0,
        "stockholders_equity": 191165000.0,
        "total_assets": 225412000.0,
        "total_liabilities": 34247000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.8671535969684004,
        "leverage": 0.17914890278032067,
        "net_margin": -0.6181620927816148,
        "operating_margin": -0.6067630340443738,
        "revenue_growth_yoy": 0.4470757324488668,
        "roa_avg2y": -0.2845597079491021,
        "roa_period_end": -0.17947136798395827,
        "roe_avg2y": -1.0253063500310469,
        "roe_period_end": -0.21162346663876755
      }
    },
    {
      "accn": "0001193125-26-067238",
      "filed": "2026-02-24",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 983000.0,
        "cash": 34495000.0,
        "cost_of_revenue": 7062000.0,
        "eps_diluted": -5.56,
        "free_cash_flow": -30142000.0,
        "gross_profit": 38163000.0,
        "net_income": -29464000.0,
        "operating_cash_flow": -29159000.0,
        "operating_income": -30041000.0,
        "revenue": 45225000.0,
        "stockholders_equity": -112252000.0,
        "total_assets": 58922000.0,
        "total_liabilities": 23762000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.8438474295190713,
        "net_margin": -0.6514980652294085,
        "operating_margin": -0.6642564953012715,
        "roa_period_end": -0.5000509147686772,
        "roe_avg2y": 0.29664233576642335
      }
    },
    {
      "accn": "0000950170-25-026773",
      "filed": "2025-02-25",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -86398000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-067238",
    "filed": "2026-02-24",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "3845",
  "sic_description": "Electromedical & Electrotherapeutic Apparatus",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001861107.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001861107.json"
  },
  "ticker": "CBLL"
}